2024 年至 2031 年核酸分离和纯化市场（按最终用户、方法、核酸类型和地区划分）

2024 年至 2031 年核酸分离与纯化市场评估

随着对精确分子诊断和标靶治疗的需求不断增长，对个人化医疗的不断增长的需求预计将成为核酸分离和纯化市场的主要驱动力。根据Verified Market Research分析师预测，2024年核酸分离与纯化市值约48.8亿美元，预测期间将达到87.8亿美元的估值。

核酸分离和纯化市场的快速扩张主要得益于生物技术和基因组学的不断进步，预计这将大幅提高市场复合年增长率。预计这将有助于市场在 2024 年至 2031 年期间以 8.40% 的复合年增长率成长。

核酸分离与纯化市场定义/概述

核酸分离与纯化是分子生物学中的一个重要过程，旨在从生物样本中提取和纯化DNA、RNA和其他核酸。这些过程对于各种应用至关重要，包括基因研究、诊断和治疗开发。有许多不同的技术用于分离和纯化核酸，包括离心、过滤和基于磁珠的方法。这些步骤中获得的核酸的品质和完整性对于后续的分析和应用至关重要。

生物技术和基因组学的不断进步正在推动核酸分离和纯化市场的显着成长。个人化医疗的不断增长的需求和高通量测序技术的进步预计将促进该市场的扩张。随着研究和临床应用的不断发展，对高效、可靠的核酸分离和纯化方法的需求预计将支持整体市场的成长。

推动核酸分离和纯化市场成长的主要趋势是什么？

新一代定序 (NGS) 技术的日益普及极大地推动了核酸分离和纯化市场的扩张。 NGS 技术为基因研究、个人化医疗和肿瘤学等各种应用提供了必需的高通量定序能力，彻底改变了基因组研究。根据 Verified Market Research 的数据，2024 年下一代定序 (NGS) 市场规模价值 88.7 亿美元，预计到 2031 年将达到 391.5 亿美元，2024-2031 年预测期内的复合年增长率为 20.39%。达到10万美元。

对精确、准确的定序结果的需求推动了对高品质核酸样本的需求，预计这将进一步推动核酸分离和纯化产品市场的发展。因此，分离和纯化技术的进步有望提高NGS的效率和有效性，从而促进市场成长。

影响核酸分离和纯化市场的关键阻碍因素有哪些？

由于先进分离纯化设备的成本较高，核酸分离纯化市场面临很大的阻碍因素。对于许多实验室，特别是发展中地区的实验室来说，复杂的技术和试剂所需的初始投资是难以承受的。

例如，自动化液体处理平台和高通量纯化机等先进系统的成本可能超过 100,000 美元，从而限制了它们的可及性和采用。预计如此高的成本将抑制市场成长，尤其是在预算受限的地区。预计全球核酸分离和纯化产品市场在资本取得有限的地区成长速度会较慢。因此，设备和试剂的高成本预计将成为市场扩张的重大障碍，影响整个产业的成长轨迹。

目录

第 1 章简介

• 市场定义
• 市场区隔
• 研究方法

第 2 章执行摘要

• 主要发现 市场概况
• 市场亮点

第三章 市场概览

• 市场规模与成长潜力
• 市场趋势
• 市场推动因素
• 市场限制
• 市场机会
• 波特五力分析

第 4 章 核酸分离与纯化市场（依最终使用者）

• 医院和诊断中心
• 学术研究机构
• 製药和生技公司
• 合约研究组织 (CRO)
• 其他最终用户

第五章 核酸分离与纯化市场（依方法）

• 基于列的分离 磁珠分离
• 其他方式

第六章 核酸分离与纯化市场（以核酸类型）

• 基因组 DNA 分离
• 质粒 DNA 分离
• RNA分离
• MicroRNA（miRNA）分离

第 7 章 区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利 亚太地区
• 中国
• 日本
• 印度
• 澳大利亚
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯联合大公国

第 8 章 市场动态

• 市场推动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第 9 章 竞争格局

• 大型公司
• 市占率分析

第十章 公司简介

• QIAGEN N.V.（Netherlands）
• Thermo Fisher Scientific Inc.（US）
• Roche Diagnostics（Switzerland）
• Promega Corporation（US）
• Agilent Technologies Inc.（US）
• Merck KGaA, Darmstadt, Germany
• Beckman Coulter Life Sciences（US）
• GE Healthcare（US）
• Bio-Rad Laboratories, Inc.（US）
• Luminex Corporation（US）

第 11 章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第 12 章附录

• 缩写列表
• 来源与参考文献

Nucleic Acid Isolation And Purification Market Valuation - 2024-2031

Increasing demand for personalized medicine is expected to be a key driver in the nucleic acid isolation and purification market, as the need for precise molecular diagnostics and targeted therapies continues to grow. According to the analyst from Verified Market Research, the Nucleic Acid Isolation And Purification Market is estimated to reach a valuation of USD 8.78 Billion over the forecast subjugating around USD 4.88 Billion valued in 2024.

The rapid expansion of the nucleic acid isolation and purification market is primarily driven by the growing advancements in biotechnology and genomics, which are anticipated to significantly boost the CAGR of the market. It enables the market to grow at aCAGR of 8.40% from 2024 to 2031.

Nucleic Acid Isolation And Purification Market: Definition/ Overview

Nucleic acid isolation and purification are critical processes in molecular biology, designed to extract and purify DNA, RNA, or other nucleic acids from biological samples. These processes are essential for a range of applications, including genetic research, diagnostics, and therapeutic development. Techniques employed in nucleic acid isolation and purification are varied and include methods such as centrifugation, filtration, and magnetic bead-based approaches. The quality and integrity of nucleic acids obtained through these processes are crucial for subsequent analysis and applications.

Increasing advancements in biotechnology and genomics are driving significant growth in the nucleic acid isolation and purification market. The rising demand for personalized medicine and advancements in high-throughput sequencing technologies are expected to contribute to this market's expansion. As research and clinical applications continue to evolve, the necessity for efficient and reliable nucleic acid isolation and purification methods is projected to increase, supporting the overall market growth.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

What are the Key Trends Driving Growth in the Nucleic Acid Isolation and Purification Market?

The expansion of the nucleic acid isolation and purification market is being significantly driven by the increasing adoption of next-generation sequencing (NGS) technologies. NGS technologies have revolutionized genomic research by providing high-throughput sequencing capabilities, which are essential for a variety of applications, including genetic research, personalized medicine, and oncology. According the Verified Market Research, the next-generation sequencing (NGS) market size was valued to be USD 8.87 Billion in the year 2024 and it is expected to reach USD 39.15 Billion in 2031, at a CAGR of 20.39% over the forecast period of 2024 to 2031.

The demand for high-quality nucleic acid samples is being propelled by the need for precise and accurate sequencing results, which is expected to further boost the market for nucleic acid isolation and purification products. Consequently, advancements in isolation and purification technologies are being anticipated to enhance the efficiency and effectiveness of NGS, leading to increased market growth.

What are the Key Restraints Affecting the Nucleic Acid Isolation and Purification Market?

The nucleic acid isolation and purification market faces significant constraints due to the high cost of advanced isolation and purification equipment. The initial investment required for sophisticated technologies and reagents can be prohibitive for many laboratories, particularly those in developing regions.

For instance, advanced systems such as automated liquid handling platforms and high-throughput purifiers can cost upwards of $100,000, which limits their accessibility and adoption. This high cost is projected to restrain market growth, particularly in regions where budget constraints are prevalent. It is estimated that the global market for nucleic acid isolation and purification products will experience slower growth rates in regions with less funding availability. Thus, the high cost of equipment and reagents is expected to be a significant barrier to market expansion, impacting the overall growth trajectory of the industry.

Category-Wise Acumens

Which is the Dominating End-User Segment in the Nucleic Acid Isolation and Purification Market?

According to VMR analyst, pharmaceutical and biotechnology companies are expected to dominate as the leading end-user segment. This dominance is attributed to the extensive use of nucleic acid isolation and purification techniques in drug discovery, development, and personalized medicine. It is anticipated that these companies will continue to drive demand due to their need for high-quality nucleic acid samples for genetic research, biomarker discovery, and therapeutic development.

The pharmaceutical and biotechnology sector is projected to account for the largest share of the market, driven by the increasing number of drug development projects and rising investments in biotechnology research.

Which Nucleic Acid Type is Expected to Experience Rapid Growth in the Nucleic Acid Isolation and Purification Market?

In the nucleic acid isolation and purification market, RNA isolation is projected to experience rapid growth compared to other nucleic acid types. This growth is largely driven by the rising prevalence of RNA-based therapies and the increasing use of RNA in molecular diagnostics and research.

The growing interest in RNA sequencing and the development of RNA-targeted treatments are anticipated to fuel demand for RNA isolation products. The RNA isolation segment is expected to witness a significant increase in market share, driven by advancements in RNA extraction technologies and the expanding applications of RNA in personalized medicine.

Country/Region-wise Acumens

What are the Key Factors Driving the Growth of the Nucleic Acid Isolation and Purification Market in North America?

According to VMR Analyst, in North America, the nucleic acid isolation and purification market is expected to experience substantial growth, driven by several key factors. The region's advanced healthcare infrastructure, significant investments in research and development, and high concentration of leading pharmaceutical and biotechnology companies are anticipated to contribute to its dominance.

The U.S. government allocated over USD 3.8 Billion to the

Human Genome Project

between 1990 and 2003, with funding provided by the National Institutes of Health (NIH) and the Department of Energy (DOE). Additionally, the NIH's "All of Us" Research Program has been granted USD 1.5 Billion over ten years starting from 2016. This initiative aims to enhance precision medicine by gathering comprehensive health data from a diverse population to better understand the impact of individual differences on health and treatment.

Additionally, the strong presence of academic research institutes and diagnostic centers in North America is likely to further support market expansion. The increasing adoption of next-generation sequencing (NGS) technologies and rising demand for personalized medicine are projected to drive the need for efficient nucleic acid isolation and purification solutions.

How is the Nucleic Acid Isolation and Purification Market Expected to Evolve in Asia Pacific?

In Asia Pacific, the nucleic acid isolation and purification market is projected to grow rapidly due to increasing investments in healthcare infrastructure and expanding research activities. The region's growing emphasis on biotechnology and genomics research, coupled with rising government funding for scientific research, is anticipated to drive market growth.

The increasing prevalence of chronic diseases and the expansion of diagnostic services are also expected to contribute to the demand for nucleic acid isolation and purification products. Moreover, the rise of local pharmaceutical and biotechnology companies and contract research organizations (CROs) is likely to further accelerate market expansion.

In 2020, Asia accounted for approximately 49.3% of global cancer cases, with around 9.5 million new diagnoses reported. However, the region's share of cancer-related deaths was notably higher, representing about 58.3% of the global total, translating to approximately 5.8 million fatalities. These statistics highlight Asia's significant burden of cancer, reflecting both the high incidence and mortality rates within the region.

Competitive Landscape

The Nucleic Acid Isolation And Purification Market's competitive landscape is characterized by a varied range of companies, including technology developers, plant operators, and service providers, all striving for market share in an increasingly dynamic and growing industry.

Some of the prominent players operating in the nucleic acid isolation and purification market include:

Agilent Technologies, Inc.

Beckman Coulter Life Sciences

Bio-Rad Laboratories, Inc.

GE Healthcare

Luminex Corporation

Merck KGaA

Promega Corporation

QIAGEN N.V.

Roche Diagnostics

Thermo Fisher Scientific, Inc.

Latest Developments

In December 2023, Thermo Fisher Scientific Inc. introduced two new products: the Thermo Scientific KingFisher Apex Dx, an automated nucleic acid purification instrument, and the Applied Biosystems MagMAX Dx Pathogen/Viral NA Isolation Kit. These innovations are designed to enhance the isolation and purification of bacterial and viral pathogens from biological samples.

In November 2023, LGC Biosearch Technologies announced the acquisition of PolyDesign, a company specializing in solid support embedded frits used for DNA and RNA oligonucleotide synthesis and purification. This technology complements LGC's Nucleic Acid Chemistry product range.

In August 2023, CD Bioparticles introduced a new series of DNA Extraction and Purification Kits. These kits are designed for efficient and rapid isolation of various DNA types, including plasmid, genomic, cell-free (cfDNA), mitochondrial, tissue DNA, and PCR products.

In July 2023, INOVIQ Limited and Promega Corporation revealed a global marketing collaboration to promote Promega's Nucleic Acid purification systems and EXO-NET exosome capture technology.

In February 2023, Agilent Technologies, Inc. selected Fluor Corporation's Advanced Technologies & Life Sciences division to expand its oligonucleotide therapeutics manufacturing facility in Colorado, enhancing capabilities for synthesizing, lyophilizing, and purifying custom nucleic acid therapeutics.

In January 2023, QIAGEN launched the EZ2 Connect MDx platform, an automated solution for diagnostic labs that streamlines the purification of DNA and RNA from up to 24 samples in under 30 minutes.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Nucleic Acid Isolation And Purification Market, By The End User

• Hospitals and Diagnostic Centers
• Academic Research Institutes
• Pharma and Biotech Companies
• Contract Research Organizations (CROs)
• Additional Final Users

5. Nucleic Acid Isolation And Purification Market, By Method

• Column-based Isolation
• Magnetic Bead-based Isolation
• Other Methods

6. Nucleic Acid Isolation And Purification Market, By Nucleic Acid Type

• Genomic DNA Isolation
• Plasmid DNA Isolation
• RNA Isolation
• MicroRNA (miRNA) Isolation

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• QIAGEN N.V. (Netherlands)
• Thermo Fisher Scientific Inc. (US)
• Roche Diagnostics (Switzerland)
• Promega Corporation (US)
• Agilent Technologies Inc. (US)
• Merck KGaA, Darmstadt, Germany
• Beckman Coulter Life Sciences (US)
• GE Healthcare (US)
• Bio-Rad Laboratories, Inc. (US)
• Luminex Corporation (US)

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References